Top 10 Companies in the Labelled Protein Market (2026): Market Leaders Powering Global Research

MARKET INSIGHTS

Global labelled protein market size was valued at USD 1.45 billion in 2024. The market is projected to grow from USD 1.58 billion in 2025 to USD 2.87 billion by 2032, exhibiting a CAGR of 7.8% during the forecast period.

Labelled proteins are biologically active molecules conjugated with markers such as fluorescent dyes, enzymes, or radioactive isotopes for detection and quantification in research and diagnostics. These specialized proteins play crucial roles in applications ranging from fluorescence microscopy and cell analysis to mass spectrometry and immune technology. The market primarily includes fluorescent marker proteins, FITC‑labelled proteins, PE‑labelled proteins, and biotinylated proteins.

Market growth is driven by increasing R&D expenditure in life sciences, which reached USD 245 billion globally in 2023, coupled with rising demand for advanced protein analysis techniques. While North America currently holds the largest market share (42% in 2024), Asia‑Pacific is expected to witness the fastest growth due to expanding biotechnology sectors in China and India. Strategic collaborations, such as Thermo Fisher Scientific’s 2024 acquisition of a leading protein labelling technology firm, are further accelerating market expansion.

Labelled Protein Market – View in Detailed Research Report

Top 10 Companies in the Labelled Protein Market (2026)

1️⃣ Thermo Fisher Scientific

Headquarters: Waltham, Massachusetts, USA
Key Offering: Comprehensive portfolio of fluorescent, enzyme‑linked, and biotinylated proteins for research, diagnostics, and drug discovery.

Thermo Fisher Scientific has positioned itself as the go‑to supplier for life‑science laboratories worldwide, leveraging its extensive R&D pipeline and global distribution network. The company’s recent acquisition of a specialist protein labelling firm has expanded its chemical conjugation capabilities, allowing customers to access higher‑throughput, site‑specific tagging solutions that reduce assay development time.

Sustainability & Growth Initiatives:

• Investment in green chemistry for fluorophore synthesis to lower hazardous waste.
• Expansion of the BioTech Innovation Hub in Shanghai to tap emerging Asian markets.
• Launch of a cloud‑based assay design platform that integrates labelled protein data with machine‑learning analytics.

2️⃣ Merck Group

Headquarters: Darmstadt, Germany
Key Offering: High‑purity FITC‑labelled proteins and biotinylated reagents for immunoassays and cell‑based screening.

Merck’s long‑standing expertise in antibody engineering complements its protein labelling arm, enabling the company to offer fully integrated solutions for therapeutic antibody development. Recent R&D focus on photostable fluorophores has positioned Merck as a leader in fluorescence microscopy reagents.

Sustainability & Growth Initiatives:

• Commitment to 50% renewable energy usage across manufacturing sites by 2030.
• Partnerships with academic consortia to develop low‑toxicity labeling chemistries.
• Strategic investment in AI‑driven protein‑interaction mapping.

3️⃣ Bio‑Rad Laboratories

Headquarters: Hercules, California, USA
Key Offering: PE‑labelled proteins and a range of analytical‑grade reagents for proteomics and diagnostics.

Bio‑Rad’s strength lies in its robust analytical platform, enabling precise quantification of labelled proteins in complex biological matrices. The company’s recent launch of a modular labelling kit streamlines workflow for CROs and academic labs, reducing turnaround times by up to 30%.

Sustainability & Growth Initiatives:

• Development of biodegradable polymer carriers for protein conjugation.
• Expansion of the Global Innovation Center in Singapore to accelerate product commercialization in Asia‑Pacific.
• Investment in open‑source software for protein labeling data sharing.

4️⃣ Jena Bioscience GmbH

Headquarters: Jena, Germany
Key Offering: Site‑specific enzymatic labeling kits and custom‑labelled proteins for structural biology.

Jena Bioscience’s niche focus on enzymatic labeling has attracted high‑profile structural biology labs seeking precise, stoichiometric protein tags. The company’s recent collaboration with the Max Planck Institute has accelerated the development of novel fluorophores with improved photostability.

Sustainability & Growth Initiatives:

• Adoption of closed‑loop production processes to minimize waste.
• Expansion of the Jena Bio‑Lab to support emerging markets in Latin America.
• Investment in a cloud‑based data platform for real‑time labelling analytics.

5️⃣ MedChemExpress

Headquarters: New Jersey, USA
Key Offering: Custom‑labelled proteins for high‑throughput screening and drug discovery.

MedChemExpress has built a reputation for rapid turnaround and high‑quality custom labelling services. Its recent partnership with a leading CRO network has expanded access to its protein conjugation platform across North America and Europe.

Sustainability & Growth Initiatives:

• Implementation of a zero‑waste policy in the manufacturing facility.
• Launch of a sustainability reporting portal for customers.
• Investment in advanced conjugation robotics to increase throughput.

6️⃣ ACROBiosystems

Headquarters: Rockville, Maryland, USA
Key Offering: High‑purity biotinylated proteins and affinity‑based detection kits.

ACROBiosystems focuses on delivering high‑performance affinity reagents for ELISA, Western blotting, and pull‑down assays. Its recent development of a next‑generation streptavidin platform enhances binding kinetics, improving assay sensitivity.

Sustainability & Growth Initiatives:

• Reduction of solvent usage by 20% through streamlined synthesis routes.
• Partnership with the EU Horizon 2020 program to develop eco‑friendly labeling chemistries.
• Expansion of the U.S. service center to support rapid delivery to biotech hubs.

7️⃣ Cytiva

Headquarters: Marlborough, Massachusetts, USA
Key Offering: Purification‑grade labelled proteins and downstream processing solutions.

Cytiva’s integration of protein purification and labeling technologies offers a one‑stop solution for biopharmaceutical manufacturers. Its recent launch of a scalable conjugation platform supports the growing demand for antibody‑drug conjugates (ADCs).

Sustainability & Growth Initiatives:

• Implementation of renewable energy across production sites.
• Development of a closed‑loop water recycling system.
• Investment in digital twins for process optimization.

8️⃣ Solarbio

Headquarters: Shanghai, China
Key Offering: Fluorescent marker proteins and mass‑spectrometry‑compatible labelled reagents.

Solarbio has carved out a strong presence in the Asian market by offering cost‑effective, high‑performance labelled proteins. Its recent expansion into the U.S. market has been supported by a joint venture with a leading U.S. distributor.

Sustainability & Growth Initiatives:

• Adoption of solar‑powered manufacturing lines.
• Collaboration with Chinese universities to develop biodegradable fluorophores.
• Launch of a regional R&D center in Singapore.

9️⃣ New England Biolabs

Headquarters: Ipswich, Massachusetts, USA
Key Offering: Enzymatic labeling kits for nucleic acid and protein conjugation.

New England Biolabs leverages its expertise in enzymology to offer precise, site‑specific labeling solutions. The company’s recent partnership with a global pharmaceutical group has accelerated the adoption of its enzymes in ADC development.

Sustainability & Growth Initiatives:

• Reduction of single‑use plastic components.
• Investment in carbon‑neutral shipping for global customers.
• Launch of an open‑access platform for enzyme‑labelling data.

🔟 GenScript

Headquarters: New York, USA
Key Offering: Custom‑labelled proteins for viral research and vaccine development.

GenScript’s focus on viral protein labelling has positioned it as a key supplier for COVID‑19 vaccine research and emerging pathogen studies. Its recent investment in a high‑throughput conjugation platform has reduced labeling times for large protein panels.

Sustainability & Growth Initiatives:

• Implementation of a green chemistry program for fluorophore synthesis.
• Partnership with global health organizations to support low‑resource laboratories.
• Expansion of the GenScript Innovation Center in Shanghai to accelerate product development.

Labelled Protein Market – View in Detailed Research Report

Labelled Protein Market – View in Detailed Research Report

OUTLOOK

In 2026, the labelled protein market is expected to reach USD 1.70 billion, driven by a 7.8% CAGR that continues to be fueled by the acceleration of proteomics and cell‑based screening technologies. The Asia‑Pacific region will lead growth, with China and India accounting for more than 35% of the global expansion, while North America will maintain a robust 40% share due to its entrenched R&D ecosystem and stringent regulatory requirements.

Future Trends

• Site‑specific conjugation technologies are becoming mainstream, enabling precise stoichiometry for antibody‑drug conjugates and advanced imaging probes.
• Photostable fluorophores with extended shelf‑life and reduced photobleaching are in high demand for long‑term imaging studies.
• Integration of AI and machine learning into assay design is accelerating discovery cycles and reducing costs.
• Regulatory harmonization across regions is simplifying market entry for new products, encouraging innovation in low‑cost labeling solutions.